Dry Eye Disease: Bridging Systemic Inflammation, Ocular Surface Biology, and Clinical Innovation
Author:
Open Access
- 17 March 2026
- journal article
- editorial
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 684
Abstract
Dry eye disease (DED) is a prevalent and complex disease of the ocular surfaceKeywords
This publication has 10 references indexed in Scilit:
- Prevalence of Meibomian Gland Dysfunction in Patients with Keratoconus in an Optometry Clinic in the Palestinian AuthorityBiomedicines, 2026
- Association Between Sleep Apnea and Dry Eye Disease in the All-of-Us ProgramBiomedicines, 2025
- Impact of Positive Airway Pressure and Mask Leakage on Dry Eye and Glaucoma Risk in Obstructive Sleep Apnea: A Cross-Sectional AnalysisBiomedicines, 2025
- The Relationship Between Composite Inflammatory Indices and Dry Eye in Hashimoto’s Disease-Induced Hypothyroid PatientsBiomedicines, 2025
- The Impact of Dry Eye Disease on Corneal Biomechanics Analyzed with Corneal Visualization Scheimpflug TechnologyBiomedicines, 2025
- Comparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-AnalysisBiomedicines, 2025
- Functional and Emotional Impact of Dry Eye and Meibomian Gland Dysfunction in KeratoconusBiomedicines, 2025
- TFOS DEWS III: Diagnostic MethodologyAmerican Journal of Ophthalmology, 2025
- Evaluating Magnetic Stimulation as an Innovative Approach for Treating Dry Eye Disease: An Initial Safety and Efficacy StudyBiomedicines, 2025
- TFOS DEWS II Epidemiology ReportThe Ocular Surface, 2017